Gyre Therapeutics Inc (GYRE)

Operating Income Growth

-438.26%

TTM · Period ending:

GYRE logo

GYRE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-438.26%
GYRE TTM Operating Income YoY % (465056.97% → -438.26%)
High-resolution chart · PNG

GYRE operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Gyre Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-438.2633%
-143.62%
-56.3867%
110.0189%
107.2984%
115.847%
124.1395%
-362.2649%
-424.0488%
-748.3747%
-499.5719%
180.2809%
131.5974%
112.6651%
87.2426%
58.1964%
14.665%
-7.2478%
-53.2055%
-64.5632%
-55.7981%
-60.2796%
-0.1624%
4.4712%
1.0235%
-8.806%
-69.3484%
-96.5674%
-96.5647%
-76.1488%
-54.9904%
-31.839%
-21.1574%
-21.5406%
-6.8711%
-6.6891%
-16.5651%
-14.1407%
-3.1836%
-939.2993%
-1,526.2243%
-580.823%
-163.5371%
106.1868%
102.7256%
94.9189%
84.0965%
23.6745%
-2.9455%
-175.5626%
-480.1917%
-2,379.8814%
-1,285.7494%
8.2897%
16.4905%
-111.3898%
-130.1733%
-209.4555%
-174.3042%
92.1235%
180.7528%
165.0321%
132.5241%
37.8517%
-100.0948%
-100.0974%
-100.0906%
-100.153%
244.698%
186.0074%
190.4344%
1,377.8205%
-120.2216%
-134.2254%
-135.3619%
-100.8147%
-41.249%
140.5667%
465,056.9724%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.